Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Consolidated net loss	$ (554,789)	$ (340,754)
Adjustments to reconcile net loss including noncontrolling interests to net cash and cash equivalents provided by operations:
Depreciation and amortization	100,011	53,493
Stock-based compensation expense	397,266	258,683
Operating lease non-cash expense	44,753	30,300
(Accretion)/amortization on marketable securities, net	(31,745)	0
Amortization of debt issuance costs	651	622
Impairment expense, (gain)/loss on investment and other asset sales, and other, net	6,169	1,481
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	122,628	118,318
Accounts payable	1,576	(10,635)
Prepaid expenses and other current assets	(6,159)	(26,923)
Other assets	(6,691)	764
Developer exchange liability	(11,156)	(16,714)
Accrued expenses and other current liabilities	(22,344)	4,340
Other long-term liability	2,286	(579)
Operating lease liabilities	(30,843)	(21,730)
Deferred revenue	229,155	148,937
Deferred cost of revenue	(38,597)	(16,670)
Net cash and cash equivalents provided by operating activities	202,171	182,933
Cash flows from investing activities:
Acquisition of property and equipment	(202,274)	(135,602)
Payments related to business combination, net of cash acquired	0	(6,165)
Purchases of intangible assets	(13,500)	0
Purchases of investments	(3,042,760)	0
Maturities of investments	324,010	0
Sales of investments	229,279	0
Net cash and cash equivalents used in investing activities	(2,705,245)	(141,767)
Cash flows from financing activities:
Proceeds from issuance of common stock	31,107	29,876
Payment of withholding taxes related to net share settlement of restricted stock units	0	(150)
Proceeds from debt issuances	14,700	0
Payment of debt issuance costs	0	(154)
Payments related to business combination, after acquisition date	(750)	0
Payment of term license related obligations	0	(420)
Net cash and cash equivalents provided by financing activities	45,057	29,152
Effect of exchange rate changes on cash and cash equivalents	807	857
Net increase/(decrease) in cash and cash equivalents	(2,457,210)	71,175
Cash and cash equivalents
Beginning of period	2,977,474	3,004,300
End of period	520,264	3,075,475
Supplemental disclosure of noncash investing and financing activities:
Property and equipment additions in accounts payable and accrued expenses and other liabilities	41,263	114,610
Fair value of common stock and unregistered restricted stock units issued as consideration for business combination	$ 0	$ 10,138